Mipletamig continues to perform, delivers 87% clinical benefit and 81% remission in frontline AML, with no CRS in frontline ...

Q1 2026 Management View "In April, we completed an oversubscribed public offering resulting in $225 million in gross proceeds" and "the proceeds from the April offering, along with our existing funds, ...

The future of the historic Greenville Pickens Speedway, a legendary NASCAR track, has been under threat for a long time.

Arbutus Biopharma targets chronic hepatitis B with Imdusiran, addressing a vast, unmet medical need. Read more on ABUS stock ...

Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported ...

COYA 302, an injection therapy in development for the treatment of ALS, has been awarded fast track status by the U.S. Food and Drug Administration. The therapy aims to slow ALS progression by ...

Dubai rolls out AI-powered parking cameras with automatic payments, real-time tracking and smart parking technology across ...

Phase 2b PLATEAU clinical study evaluating enobosarm + semaglutide is actively enrolling and on track for interim analysis first quarter calendar year 2027- --Company to host conference call and webca ...

Enrollment on track for Phase 3 UPSTREAM MG trial of telitacicept in generalized myasthenia gravis patients with topline results anticipated in 1H27 Enrollment ongoing for Phase 3 UPSTREAM SjD of teli ...

A monster El Niño is forming, potentially rivalling the 1877 event that killed 50 million. Discover how the 2026 forecast ...

Smith County commissioners on Tuesday rejected an independent audit on the county’s road bond program and tabled a decision ...

Q1 2026 Earnings Call May 13, 2026 10:00 AM EDTCompany ParticipantsRichard Young - President, CEO & DirectorW.